Launch of European Value Added medicines (EVA), a new EGA sector group, will deliver efficiency

12 June 2015

Brussels – The European Generic and Biosimilar medicines Association (EGA) announced […]

El Gobierno Español Todavía Tiene Margen para Promover la Competencia del Genérico

1 December 2014

Interview with Adrian van den Hoven in EV Healthcare

13 November 2014

No longer a niche market, generics are claiming new market […]

“Hay un enorme potencial para el mercado biosimilar si el marco es el adecuado”

17 March 2014

La patronal de genéricos anima a trasladar el foco desde […]